
The second part of the review concerned with investigation of nonribosomal peptides.
Ribosomal Proteins, nonribosomal peptides, Antibiotics, Antineoplastic, Lactams, Chromobacterium, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Thiones, Antineoplastic Agents, Isoquinolines, Peptides, Cyclic, Thiazoles, Anti-Infective Agents, Depsipeptides, antiviral activity, antitumor activity, Macrolides, Beauveria, Peptides, RC254-282
Ribosomal Proteins, nonribosomal peptides, Antibiotics, Antineoplastic, Lactams, Chromobacterium, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Thiones, Antineoplastic Agents, Isoquinolines, Peptides, Cyclic, Thiazoles, Anti-Infective Agents, Depsipeptides, antiviral activity, antitumor activity, Macrolides, Beauveria, Peptides, RC254-282
| citations The total number of citations received by all articles of the researcher of interest. | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
